Skip to content 
Table of Contents
Autoimmune conditions can bring daily challenges, from chronic pain to unpredictable flare-ups. For people who have not found relief with traditional therapies, advanced options like Inflectra may provide a new way forward.
What is Inflectra?
Inflectra (infliximab-dyyb) is a biosimilar to Remicade, meaning it is designed to be highly similar to the original medication in safety, quality, and effectiveness. Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis are among the autoimmune diseases that it is used to treat. Inflectra treatment can help lessen symptoms and enhance the general quality of life by addressing inflammation at its root cause.
How Does Inflectra Work in the Body
Autoimmune diseases happen when the immune system mistakenly attacks healthy tissues. This can lead to chronic inflammation, joint damage, and digestive issues, depending on the condition. Inflectra interrupts this harmful immune response.
Inflectra works by binding to a protein in the body called tumor necrosis factor-alpha (TNF-α). TNF-α plays a major role in inflammation. By blocking it, Inflectra reduces the immune system’s overreaction, calming inflammation and preventing further tissue damage.
The result can include:
- Relief from pain and swelling
- Improved physical function
- Reduction in digestive symptoms for gastrointestinal conditions
- Slower disease progression in conditions like rheumatoid arthritis and psoriatic arthritis
This targeted approach allows patients to experience symptom relief while helping protect long-term health.
What Conditions Inflectra Can Treat
Inflectra has multiple FDA-approved indications. It is not just limited to one condition, which makes it a versatile option for people living with autoimmune diseases.
Inflectra for Crohn’s Disease
Inflectra for Crohn’s disease is approved for both adults and children over 6 years old. It helps reduce signs and symptoms, induce and maintain remission, and even promote closure of fistulas in patients with fistulizing Crohn’s disease.
Ulcerative Colitis
In both adults and children, Inflectra can reduce symptoms, support mucosal healing, and help patients taper off corticosteroids. Many patients find that regular infusions help maintain long-term stability.
Inflectra for Rheumatoid Arthritis
When combined with methotrexate, Inflectra for rheumatoid arthritis can reduce joint pain, slow progression of damage, and improve mobility. For many patients, it means staying active and independent longer.
Ankylosing Spondylitis
For patients with active ankylosing spondylitis, Inflectra can decrease inflammation in the spine and joints, easing stiffness and improving movement.
Psoriatic Arthritis
Inflectra helps reduce swelling, slow damage, and restore function. Many patients experience less pain and a better range of motion in affected joints.
Plaque Psoriasis
Adults with severe plaque psoriasis who have not responded to conventional therapy may benefit from Inflectra’s ability to lessen skin symptoms and enhance quality of life.
Why Inflectra Can Be a Good Option for Autoimmune Disease Treatment
Many people with autoimmune conditions try multiple medications before finding one that works. Inflectra stands out because it directly targets TNF-α, one of the main drivers of inflammation in many of these diseases.
Some key benefits include:
- Reliable track record as a biosimilar to Remicade
- Suitable for multiple autoimmune conditions
- Proven ability to reduce symptoms and improve daily function
- Administered on a predictable schedule every six to eight weeks
Because it is a biosimilar, Inflectra may also be a more cost-effective option compared to some brand-name treatments, giving patients access to advanced therapy with the same level of safety and effectiveness.
What to Expect During Inflectra Treatment
Starting a new therapy can feel overwhelming, but knowing the process helps ease concerns. At Omega Health Clinics, patients receive their infusions in a comfortable, monitored setting.
Before Treatment
Your provider will review your medical history and may order tests to make sure Inflectra is safe for you. Pre-medications such as steroids, Benadryl, or Tylenol may be given to minimize infusion reactions.
During Infusion
Inflectra is given through an intravenous infusion. The first few treatments, known as the induction phase, may be scheduled more frequently to help the medication build up in your system. After that, most patients receive infusions every six to eight weeks. Each session typically lasts about two hours.
Observation Time
After the infusion, staff may monitor you for a short period to ensure you tolerate the treatment well. This extra step provides peace of mind and safety.
Recovery and Follow-up
After therapy, the majority of patients may immediately return to their regular activities. Seeing your doctor regularly allows you to monitor your progress and make any necessary adjustments to your treatment plan.
Who Should Consider Inflectra
Inflectra is generally recommended for patients with moderate to severe autoimmune diseases who have not responded well to conventional therapies. It is suitable for both adults and children over 6 years old for Crohn’s disease and ulcerative colitis.
You might be a candidate if you:
- Experience ongoing symptoms despite standard medications
- Have tried corticosteroids or immunosuppressants with limited success
- Need long-term relief to improve daily quality of life
- Want a treatment option that targets the underlying inflammation rather than only managing symptoms
A healthcare provider will carefully evaluate your medical history to determine if Inflectra is right for you.
Why Inflectra Works Across Different Conditions
One of the unique aspects of Inflectra is that it treats multiple autoimmune conditions with the same underlying mechanism. While Crohn’s disease affects the digestive tract and rheumatoid arthritis affects the joints, both involve TNF-α driven inflammation. By targeting this protein, Inflectra can provide relief across conditions.
This versatility makes it an important option in autoimmune disease treatment, particularly for patients who may have overlapping conditions or have not responded to other therapies.
Common Questions About Inflectra
Is Inflectra safe?
Yes. Inflectra has been studied extensively and is FDA-approved as a biosimilar to Remicade. It meets strict standards for safety and effectiveness.
How often will I need treatment?
Most patients receive infusions every six to eight weeks after the induction phase. Your doctor will personalize the schedule based on your condition and response.
Does Inflectra have side effects?
Like any medication, side effects are possible. The most common include mild infusion reactions such as headache or fatigue. Your care team will keep a careful eye on you and offer advice.
How soon will I feel results?
Some patients notice improvement after the first few infusions, while for others it may take longer. Regular monitoring helps track your progress.
Moving Forward with Inflectra
Living with an autoimmune condition can feel like an uphill battle, but effective treatment options like Inflectra give patients a chance to regain control. With its proven ability to calm inflammation, reduce symptoms, and support long-term remission, Inflectra is an important therapy for many people managing chronic illness.
If you are exploring treatment options, Omega Health Clinics provides Inflectra in Modesto, CA, with professional care and personalized attention. The team ensures that each step, from your first infusion to your regular follow-ups, is handled with expertise and compassion.
Schedule an Inflectra Consultation Today with Omega Health Clinics to learn whether Inflectra is the right fit for you. Relief from autoimmune symptoms may be closer than you think.